Phase 2 Extension Study Demonstrated Sustained Weight Loss SAN DIEGO and OSAKA, Japan, Feb. 22, 2010 (HSMN NewsFeed) — Amylin Pharmaceuticals, Inc. (Nasdaq:AMLN ) and Takeda Pharma Company Limited (TSE:4502.to ) announced today that the compa…
Biopharmaceuticals
Amylin Pharmaceuticals, Takeda Pharma, pramlintide, metreleptin

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity”
Leave a Comment